Abstract:Abstract Lung cancer is the leading cause of cancer-associated deaths accounting for 24% of all cancer deaths. As a crucial phase of tumor progression, lung cancer metastasis is linked to over 70% of these mortalities. In recent years, exosomes have received increasing research attention in their role in the induction of carcinogenesis and metastasis in the lung. In this review, recent studies on the contribution of exosomes to lung cancer metastasis are discussed, particularly highlighting the role of lung tumor-derived exosomes in immune system evasion, epithelial-mesenchymal transition, and angiogenesis, and their involvement at both the pre-metastatic and metastatic phases. The clinical application of exosomes as therapeutic drug carriers, their role in antitumor drug resistance, and their utility as predictive biomarkers in diagnosis and prognosis are also presented. The metastatic activity, a complex multistep process of cancer cell invasion, survival in blood vessels, attachment and subsequent colonization of the host's organs, is integrated with exosomal effects. Exosomes act as functional mediating factors in cell–cell communication, influencing various steps of the metastatic cascade. To this end, lung cancer cell-derived exosomes enhance cell proliferation, angiogenesis, and metastasis, regulate drug resistance, and antitumor immune activities during lung carcinogenesis, and are currently being explored as an important component in liquid biopsy assessment for diagnosing lung cancer. These nano-sized extracellular vesicles are also being explored as delivery vehicles for therapeutic molecules owing to their unique properties of biocompatibility, circulatory stability, decreased toxicity, and tumor specificity. The current knowledge of the role of exosomes highlights an array of exosome-dependent pathways and cargoes that are ripe for exploiting therapeutic targets to treat lung cancer metastasis, and for predictive value assessment in diagnosis, prognosis, and anti-tumor drug resistance.

Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer

The Roles of Tumor-Derived Exosomes in Non-Small Cell Lung Cancer and Their Clinical Implications

Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma

The Biological Functions and Clinical Applications of Exosomes in Lung Cancer

The role of exosomes in lung cancer metastasis and clinical applications: an updated review

The biology, function and clinical implications of exosomes in lung cancer

Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy

Role of exosomal microRNAs in lung cancer biology and clinical applications

Exosomal Long Non-Coding RNAs: Biological Properties and Therapeutic Potential in Cancer Treatment

Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma

Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis

The Role of Exosomes and Their Applications in Cancer

The role of exosomal lncRNAs in cancer biology and clinical management

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer

Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers

Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential

Exosomes: key players in cancer and potential therapeutic strategy

Exosomes and Their Role in Cancer Progression

Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances

Mechanisms of function and clinical potential of exosomes in esophageal squamous cell carcinoma